Multicenter Studies as Topic
"Multicenter Studies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
Descriptor ID |
D015337
|
MeSH Number(s) |
E05.318.760.658 N05.715.360.775.508 N06.850.520.450.643
|
Concept/Terms |
Multicenter Trials- Multicenter Trials
- Multicenter Trial
- Trial, Multicenter
- Trials, Multicenter
- Multicentre Trials
- Multicentre Trial
- Trial, Multicentre
- Trials, Multicentre
|
Below are MeSH descriptors whose meaning is more general than "Multicenter Studies as Topic".
Below are MeSH descriptors whose meaning is more specific than "Multicenter Studies as Topic".
This graph shows the total number of publications written about "Multicenter Studies as Topic" by people in this website by year, and whether "Multicenter Studies as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1997 | 0 | 2 | 2 |
1999 | 0 | 2 | 2 |
2000 | 0 | 4 | 4 |
2001 | 0 | 2 | 2 |
2002 | 0 | 3 | 3 |
2003 | 0 | 2 | 2 |
2004 | 0 | 3 | 3 |
2005 | 0 | 6 | 6 |
2006 | 1 | 12 | 13 |
2007 | 1 | 4 | 5 |
2008 | 1 | 4 | 5 |
2009 | 0 | 6 | 6 |
2010 | 0 | 4 | 4 |
2011 | 0 | 5 | 5 |
2012 | 3 | 6 | 9 |
2013 | 4 | 3 | 7 |
2014 | 0 | 2 | 2 |
2015 | 0 | 1 | 1 |
2016 | 2 | 3 | 5 |
2017 | 0 | 2 | 2 |
2018 | 1 | 2 | 3 |
2019 | 0 | 6 | 6 |
2020 | 1 | 4 | 5 |
2021 | 0 | 3 | 3 |
2022 | 0 | 7 | 7 |
2023 | 0 | 5 | 5 |
2024 | 0 | 6 | 6 |
2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.
-
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis. BMJ Open Gastroenterol. 2025 Jan 08; 12(1).
-
Semaglutide 2.4?mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial. Aliment Pharmacol Ther. 2024 Dec; 60(11-12):1525-1533.
-
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer. Clin Lung Cancer. 2024 Dec; 25(8):e448-e452.
-
Scaling and interpreting treatment effects in clinical trials using restricted mean survival time. Clin Trials. 2025 Feb; 22(1):3-10.
-
Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study. PLoS One. 2024; 19(5):e0303053.
-
Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol. 2024 Apr; 49(4):102417.
-
Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids. BMJ Open. 2024 01 12; 14(1):e078989.
-
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative. Circ Cardiovasc Qual Outcomes. 2023 10; 16(10):e009905.
-
Clinically Integrated Breastfeeding Peer Counseling to Promote Breastfeeding Equity. Am J Perinatol. 2024 05; 41(S 01):e2313-e2325.
-
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLoS One. 2023; 18(6):e0286297.